Premenstrual syndrome (PMS) is a condition that affects emotional behavior and physical health of women during or few days before their menstrual cycle. PMS often leads to acne, tender breasts, bloating, irritability, and mood swings , which could be managed by lifestyle changes or drug treatment. Medication such as analgesics, antidepressants, oral contraceptives and ovarian suppression agents are generally used to manage PMS.
List of Key Players
The key players profiled in this report include ABBVIE INC., AstraZeneca plc., BASF Corporation, Bayer AG, Dr. Reddy’s Laboratories Ltd, Eli Lilly And Company, GlaxoSmithKline Plc., H. Lundbeck A/S, Pfizer Inc., and Shionogi Inc.
Download Sample Report: https://www.alliedmarketresearch.com/request-sample/6330
The premenstrual syndrome treatment market is expected to experience a significant growth during the forecast period, owing to rise in demand for PMS treatment medication across the globe and increase in awareness related to PMS. Surge in number of target population is further anticipated to boost the premenstrual syndrome treatment market growth during the forecast period. According to the American Psychiatric Association, almost 90% of women of child bearing age experience premenstrual symptoms. In addition, growth in demand for premenstrual therapeutics in developing countries further creates opportunities for the premenstrual syndrome treatment market. However, unknown etiology and pathophysiology of PMS and adverse effects associated with off label drugs are anticipated to hamper the market growth.
By drug type, the market is categorized into analgesics, antidepressants, oral contraceptives & ovarian suppression agents, and others. Presently, analgesics is the major revenue contributing segment and is estimated to show the same dominance during the forecast period, owing to preferable use of Nonsteroidal anti-inflammatory (NSAIDs) as first line treatment in management of PMS.
According to distribution channel, the market is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. The online providers segment is anticipated to depict significant growth during the forecast period, due to rise in preference for online purchasing of drugs, increase in awareness of online pharmacies, and rise in number of internet users.
For Purchase inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/6330
𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.